Showing 3,041 - 3,060 results of 18,262 for search 'significantly ((((((we decrease) OR (a decrease))) OR (larger decrease))) OR (linear decrease))', query time: 0.48s Refine Results
  1. 3041
  2. 3042
  3. 3043
  4. 3044
  5. 3045
  6. 3046
  7. 3047
  8. 3048
  9. 3049
  10. 3050

    Raw data. by Saeedeh Abbasi (9423189)

    Published 2025
    “…However, both groups exhibited a significant decrease in CCI during prolonged standing (time *  condition: p =  0.003). …”
  11. 3051

    Data. by Saeedeh Abbasi (9423189)

    Published 2025
    “…However, both groups exhibited a significant decrease in CCI during prolonged standing (time *  condition: p =  0.003). …”
  12. 3052

    DataSheet1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  13. 3053

    DataSheet3_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  14. 3054

    DataSheet2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  15. 3055

    DataSheet4_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  16. 3056
  17. 3057
  18. 3058
  19. 3059
  20. 3060